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he Golgi apparatus comprises an enormous array of
components that generate its unique architecture
and function within cells. Here, we use quantitative
 
fluorescence imaging techniques and ultrastructural analysis
 
to address whether the Golgi apparatus is a steady-state or a
 
stable organelle. We found that all classes of Golgi compo-
nents are dynamically associated with this organelle, contrary
to the prediction of the stable organelle model. Enzymes and
recycling components are continuously exiting and reenter-
ing the Golgi apparatus by membrane trafficking pathways
to and from the ER, whereas Golgi matrix proteins and
coatomer undergo constant, rapid exchange between
membrane and cytoplasm. When ER to Golgi transport is
inhibited without disrupting COPII-dependent ER export
machinery (by brefeldin A treatment or expression of
Arf1[T31N]), the Golgi structure disassembles, leaving no
T
 
residual Golgi membranes. Rather, all Golgi components
redistribute into the ER, the cytoplasm, or to ER exit sites
still active for recruitment of selective membrane-bound
and peripherally associated cargos. A similar phenomenon
is induced by the constitutively active Sar1[H79G] mutant,
which has the additional effect of causing COPII-associated
 
membranes to cluster to a juxtanuclear region. In cells
expressing Sar1[T39N], a constitutively inactive form of
Sar1 that completely disrupts ER exit sites, Golgi glycosylation
enzymes, matrix, and itinerant proteins all redistribute to
the ER. These results argue against the hypothesis that the
Golgi apparatus contains stable components that can serve
as a template for its biogenesis. Instead, they suggest that
the Golgi complex is a dynamic, steady-state system, whose
membranes can be nucleated and are maintained by the
activities of the Sar1–COPII and Arf1–coatomer systems.
 
Introduction
 
Cellular structures maintain and reproduce themselves in
two fundamentally different ways: using a template or scaffold
to repair or build copies of themselves (e.g., DNA, ER,
mitochondria, and centrioles) or using self-organizing prin-
ciples to create their structure de novo (e.g., mitotic spin-
dle apparatus, nucleolus, nuclear envelope, and ribosomes)
(Maniotis and Schliwa, 1991; Ellenberg et al., 1997; Misteli,
 
2001; Bamford et al., 2001). A major controversy in or-
ganelle biology has centered on which of these two mechanisms
best describes the growth and inheritance of the Golgi com-
plex. The template model views the Golgi apparatus as an
autonomous organelle, with stable components that provide
a template or scaffold for its growth and division. The de
novo model, by contrast, envisions the Golgi apparatus as a
dynamic, steady-state structure, whose maintenance and
biogenesis depend on dynamic membrane input and out-
flow pathways.
The view of the Golgi apparatus as an organelle capable of
de novo assembly from the ER has come from studies show-
ing that a variety of conditions that interfere with protein
delivery from the ER to the Golgi apparatus cause Golgi
membrane dispersal. For example, brefeldin A (BFA)* treat-
ment, which inactivates Arf1, leads to the dissociation of
COPI and other peripheral proteins from Golgi membranes,
and results in Golgi enzymes redistributing to the ER as the
Golgi structure disassembles (for review see Klausner et al.,
1992). Upon BFA washout, the Golgi system reforms as
Golgi proteins are exported from the ER. Microtubule dis-
ruption by nocodazole prevents ER-derived transport inter-
mediates from tracking to the microtubule organizing center
(MTOC), and results in Golgi proteins reversibly redistrib-
uting to ER exit sites where they assemble into hundreds of
Golgi ministacks (Cole et al., 1996a; Presley et al., 1997;
Storrie et al., 1998; Zaal et al., 1999). Overexpression of a
constitutively inactive Sar1 protein (Sar1[T39N]), which
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inhibits COPII-dependent ER export (Barlowe et al., 1994;
Kuge et al., 1994), leads to the redistribution of Golgi en-
zymes to the ER and Golgi structure disassembly (Zaal et al.,
1999; Prescott et al., 2001). These findings suggest that
Golgi integrity depends on the constitutive cycling of Golgi
components through the ER and when ER–Golgi transport
is inhibited, Golgi proteins redistribute to the site of the
transport block via the ER.
Recently, the view of the Golgi apparatus as a dynamic,
steady-state system has been challenged based on the obser-
vation that not all Golgi components behave in a similar
manner when ER–Golgi trafficking is perturbed. In BFA-
treated cells, rapidly cycling proteins such as ERGIC53 as
well as Golgi matrix proteins (including GRASP65 and
GM130) relocate to peripheral structures (also called Golgi
remnants) instead of the ER (Lippincott-Schwartz et al.,
1990; Hendricks et al., 1992; Nakamura et al., 1995; Tang
et al., 1995; Seemann et al., 2000). In cells expressing the
constitutively active form of Sar1 (the GTP-bound mutant
Sar1[H79G]), Golgi glycosylation enzymes again redistrib-
ute to the ER (Aridor et al., 1995; Storrie et al., 1998, See-
mann et al., 2000). However, Golgi matrix proteins in these
cells are not found in the ER but localize to a juxtanuclear
pattern reminiscent of the Golgi apparatus (Seemann et al.,
2000). These observations have raised the possibility that the
Golgi apparatus is an autonomous organelle, with some of
its components (i.e., matrix proteins) in stable association
with Golgi-specific membranes that provide a template or
scaffold for Golgi growth and division (Pelletier et al., 2000;
Seemann et al., 2000).
In this study, we test whether the Golgi apparatus con-
tains stable components that can serve as a template for
its maintenance and biogenesis. Using fluorescence pho-
tobleaching techniques, we first investigate the manner in
which green fluorescent protein (GFP)–tagged members of
different classes of Golgi proteins, including enzymes, ma-
trix proteins, coat proteins, and rapidly recycling compo-
nents, associate with Golgi membranes. The extent and time
course of fluorescence recovery after photobleaching (FRAP)
of the Golgi pool of these proteins allow us to determine
whether the Golgi protein is dynamically or stably associated
with the Golgi, and whether it constitutively cycles through
the ER or exchanges with a cytoplasmic pool. We next ex-
amine how the steady-state association of these classes of
Golgi proteins is affected under conditions that perturb ER
export, including BFA treatment and the use of mutant Arf1
and Sar1 constructs that are blocked at different stages of the
GTPase cycle. To avoid confusion, we refer to these mutants
throughout by their specific amino acid changes. Thus, the
GTP-restricted form of Sar1, previously referred to as
Sar1pDN (Seemann et al., 2000; Miles et al., 2001), is the
active mutant Sar1[H79G], the inactive GDP-bound mu-
tant of Sar1 is Sar1[T39N], and the inactive GDP-bound
mutant of Arf1 is Arf1[T31N]. As discussed below, our data
demonstrate that the Golgi apparatus is comprised of resi-
dent components that dynamically exchange with protein
pools in the ER or cytoplasm, and exists as a steady-state
membrane system dependent upon the activities of the Sar1
and Arf1 coat systems.
 
Results
 
Members of all classes of Golgi proteins dynamically 
associate with Golgi membranes
 
To investigate the manner in which members of different
classes of Golgi proteins associate with Golgi membranes
(i.e., permanently or dynamically), we used an assay involv-
ing photobleaching of the Golgi pool of these molecules
tagged with GFP (Zaal et al., 1999; Dahm et al., 2001). Sig-
nificant recovery into the Golgi area indicates that the
bleached GFP chimeras are exchanging with fluorescent
pools of the protein localized in other parts of the cell. A lack
of significant recovery indicates that the fluorescently tagged
proteins are stably associating with the Golgi membrane.
We first characterized the localization of the GFP-tagged
members of the different classes of Golgi proteins being used
in this assay (Table I, Fig. 1 A). These included: GalT–yel-
low fluorescent protein (YFP), a chimera targeted to the
Golgi membrane by the addition of the transmembrane do-
main of a Golgi resident enzyme, galactosyltransferase, to
YFP (Cole et al., 1996b); p58–YFP, a tagged full-length
transmembrane protein homologous to ERGIC53 (Lah-
tinen et al., 1992), which is involved in ER to Golgi traffick-
ing of specific cargo (Hauri et al., 2000); GRASP65–GFP, a
Golgi matrix protein (Barr et al., 1997); and 
 

 
COP–GFP,
the 
 

 
 subunit of coatomer involved in ER–Golgi and intra-
Golgi transport (Guo et al., 1994; Presley et al., 1998). In
stable cell lines, GalT–YFP and GRASP65–GFP (Fig. 1 B,
prebleach) showed bright labeling of the Golgi complex and
faint labeling of areas outside the Golgi structure. p58–YFP
and 
 

 
COP–GFP (Fig. 1 B, prebleach) labeled Golgi mem-
branes as well as numerous peripheral structures. Many of
the peripheral structures containing p58-YFP and 
 

 
COP–
GFP were ER to Golgi transport intermediates, as deter-
 
Table I.
 
Classification of Golgi protein components
Component Function Type GFP constructs tested (source)
 
Glycosylation enzymes Carbohydrate processing Type II integral 
membrane protein
GalT-GFP (Cole et al., 1996b);
ManII-GFP (Cole et al., 1996b)
Itinerant proteins Transport Type II integral 
membrane protein
p58-GFP (this study); 
p23-GFP (Blum et al., 1999); 
Sec22-GFP (Chao et al., 1999)
Scaffold proteins Structural Peripheral GRASP65-GFP (Barr et al., 1998);
GFP-GM130 (Barr et al., 1998)
Coat proteins Sorting Peripheral
 

 
COP-GFP (Presley et al., 1998)
All GFP constructs in each group behaved in the same way under all conditions tested.  Only one example is given in results.
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mined by double labeling with vesicular stomatitis virus G
protein released from the ER (unpublished data). Functional
assays for 
 

 
COP–GFP and GRASP65–GFP chimeras re-
vealed that the GFP tag had no effect on the activity of these
proteins. 
 

 
COP–GFP rescued an 
 
ldlF
 
 cell line defective in
 

 
COP at 40
 

 
C (Guo et al., 1994; Presley et al., 1998), indi-
cating that it assembles into, and can function as a part of,
the coatomer complex. GRASP65–GFP interacts with its
binding partner GM130, another component of the scaf-
fold, in biochemical experiments (not shown), and correctly
localizes to the Golgi membrane in vivo, which requires
both normal myristoylation and interaction with GM130
(Barr et al., 1998).
When the Golgi apparatus was photobleached in cells ex-
pressing GalT–YFP, fluorescence slowly recovered to the
Golgi area and became readily visible after 
 

 
50 min (Fig. 1
B, GalT–YFP), a result identical to previous experiments us-
ing GalT tagged with a triple GFP construct (Zaal et al.,
1999). In contrast, in cells expressing p58–YFP, fluores-
cence was found to recover within 15 min after selective
photobleaching of the Golgi area (Fig. 1 B, p58–YFP). This
result was not surprising, given that p58 is thought to reside
only transiently in the Golgi complex as it constitutively
traffics between the Golgi system and the ER (Itin et al.,
 
1995; Kappeler et al., 1997; Tisdale et al., 1997; Klumper-
man et al., 1998), and thus cycles much faster in and out of
Golgi membranes than GalT–YFP. We next photobleached
the Golgi area of normal rat kidney (NRK) cells stably ex-
pressing 
 

 
COP–GFP (Fig. 1 B, 
 

 
COP–GFP). Recovery of
 

 
COP–GFP fluorescence in the Golgi apparatus was rapid
and showed significant replenishment within 20 s of pho-
tobleaching, as previously described by Presley et al. (1998),
and as expected, since 
 

 
COP is a vesicle coat protein (Kreis
et al., 1995; Schekman and Orci, 1996). Surprisingly, selec-
tive photobleaching of cells expressing GRASP65–GFP re-
vealed a rapid rate of fluorescence recovery into the bleached
Golgi area (Fig. 1 B, GRASP65–GFP), comparable to that
seen for 
 

 
COP–GFP. No significant difference in the recov-
ery kinetics was observed in cells expressing different con-
centrations of GRASP65–GFP in these experiments (un-
published data). In all cases, recovery was nearly complete
within 1 min, indicating that GRASP65 is not permanently
associated with Golgi membranes.
To determine whether the fast recovery after photobleach-
ing observed for GRASP65–GFP was due to its rapid cycling
through ER–Golgi membrane pathways or to its binding and
releasing from Golgi membranes, we examined the effect of
microtubule disruption on the recovery kinetics. Microtu-
Figure 1. Localization and dynamics of different 
classes of Golgi components tagged with GFP. (A) 
Schematic representation of GFP chimeras. EGFP, 
or its spectral variants EYFP and ECFP, was fused 
in-frame with (left to right): the transmembrane 
domain and cytoplasmic tail of GalT (Cole et al., 
1996b); p58, the full-length rat homologue of 
ERGIC53 (Lahtinen et al., 1992; Hauri et al., 
2000); full-length GRASP65 (Barr et al., 1998); 
full-length COP (Presley et al., 1998). (B) The 
prebleach image shows NRK cells stably express-
ing each of the GFP chimeras. The Golgi complex 
(outlined area) was photobleached, and the 
recovery of fluorescence to the area was 
monitored. Images at representative time points 
postbleach are shown. Bars, 10 m.
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bules serve as tracks for the ER to Golgi transport of mem-
brane-bound intermediates (Presley et al., 1997). Microtu-
bule disruption, therefore, would be expected to inhibit
GRASP65–GFP dynamics if the protein were rapidly cycling
to and from the Golgi via membrane trafficking pathways,
and to have no effect if GRASP65–GFP were binding and re-
leasing from Golgi membranes. Microtubules were depoly-
merized on ice for 15 min and then cells were rewarmed to
37
 

 
C in the presence of nocodazole to prevent polymerization
of new microtubules. The Golgi pool of the GFP chimera was
photobleached immediately upon warmup (i.e., before frag-
mentation of the Golgi stacks) and recovery was monitored
over time. No effect on the recovery kinetics of GRASP65–
GFP was found (Fig. 2, GRASP65–GFP). Microtubule dis-
ruption also did not affect the Golgi recovery kinetics of
 

 
COP–GFP (Fig. 2, 
 

 
COP–GFP). In contrast, microtubule
disruption significantly slowed the recovery kinetics of p58–
GFP into the bleached Golgi area (Fig. 2, p58–GFP; compare
4 min time point to Fig. 1 B), as expected, given that p58 is
delivered to the Golgi area by transport intermediates that use
microtubules (Saraste and Svensson, 1991). These results sug-
gest that GRASP65–GFP continuously associates with and
dissociates from Golgi membranes in a manner reminiscent
of Golgi coat proteins, presumably from a cytosolic pool.
Conversely, by repetitively photobleaching an area of the cy-
tosol (Cole et al., 1996b; Zaal et al., 1999), we could deplete
the Golgi pool of GRASP65–GFP (unpublished data), indi-
cating that GRASP65–GFP fluorescence on the Golgi appa-
ratus is dependent on a constant supply from the cytosol.
Quantitation of GRASP65–GFP fluorescence revealed that
protein found in the cytosolic pool was in the range of 29–
55% of the cell total within the stable cell line. When we
looked at the relative distribution of endogenous GRASP65
(Fig. S1 available online at http://www.jcb.org/cgi/content/
full/jcb.200107045/DC1) we found that 25–30% of the pro-
 
tein was found in a cytosolic pool, confirming that the GFP
chimera was reflecting the activity of the endogenous protein.
Our combined results examining the association of GFP-
tagged members from different Golgi protein classes reveal
that none are stably associated with the Golgi complex:
GalT–YFP and p58–YFP continuously exit and reenter the
Golgi complex using membrane transport pathways that
connect the Golgi apparatus with the ER membrane system,
whereas 
 

 
COP–GFP and GRASP65–GFP rapidly bind and
release Golgi membranes from a cytosolic pool.
 
Disruption of the steady-state distribution of Golgi 
components by BFA
 
To examine how the steady-state association of the different
Golgi proteins is affected under different conditions, we
treated cells with BFA, which has a marked effect on the ar-
chitecture of the Golgi complex. During BFA treatment,
coat proteins, such as COPI, dissociate from Golgi mem-
branes and Golgi glycosylation enzymes are redistributed to
the ER (Klausner et al., 1992). In addition, recycling pro-
teins, such as ERGIC53/p58 and the p24 family, as well as
Golgi matrix proteins, such as GRASP65 and GM130, ap-
pear in peripheral structures (Lippincott-Schwartz et al.,
1990; Nakamura et al., 1995; Tang et al., 1995; Blum et al.,
1999; Seemann et al., 2000). These structures are often de-
scribed as Golgi remnants since they are thought to be left
behind after BFA-induced ER redistribution of Golgi en-
zymes (Hendricks et al., 1992; Seemann et al., 2000).
We used the GFP-tagged Golgi proteins to study the forma-
tion of these BFA remnants in vivo. A single cell expressing
each construct before and after BFA treatment is shown in Fig.
3 A. After 30 min of BFA treatment, the distribution of all of
these proteins resembled that previously described after anti-
body staining procedures: GalT–GFP was in the ER, 
 

 
COP–
Figure 2. Blocking ER to Golgi transport by 
microtubule disruption differentiates between 
membrane-bound and cytosolically exchanging 
Golgi components in photobleaching assays. NRK 
cells stably expressing p58–GFP, GRASP65–GFP 
and COP–GFP were incubated on ice for 15 min 
to depolymerize microtubules. Nocodazole was 
added at 1 g/ml to prevent microtubule polymer-
ization upon warmup to 37C. The Golgi complex 
(outlined area) was photobleached immediately 
after cells reached the microscope stage (i.e., 
at a stage before nocodazole-induced Golgi 
fragmentation) and recovery of fluorescence to the 
area was monitored. Images at representative time 
points after bleaching are shown. Bars, 10 m.
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Figure 3. In vivo redistribution of Golgi components upon treatment with BFA. (A) All classes of GFP-tagged Golgi proteins show the 
expected pattern of localization before and after BFA treatment. Cells expressing each of the indicated constructs were imaged on the micro-
scope stage (untreated). BFA was then added, 5 g/ml, and 30 min after addition the same cells were imaged again (BFA). (B) Time series of 
cells expressing GRASP65–GFP immediately after the addition of BFA (5 g/ml). GRASP65–GFP redistributes to peripheral puncta before the 
loss of its Golgi pool (1 and 2 min; arrows). In both cases, the punctate structures do not track out from the Golgi region (see Video1). Bars: 
(A) 10 m; (B) 5 m. Video available at http://www.jcb.org/cgi/content/full/jcb/200107045/DC1.
Figure 4. BFA remnants localize to ER 
exit sites. (A) ImmunoEM showing distri-
bution of either Sec13–YFP or p58–GFP 
in NRK stable cell lines either left un-
treated or treated with BFA. Sec13–YFP 
labels membranes closely associated 
with VTCs, whereas p58–GFP is found 
both on the clusters and in surrounding 
ER membranes. (B) Characterization by 
light microscopy of cells treated with 
BFA. Sec13–YFP, transfected  p58–CFP, 
and GRASP65–GFP stable NRKs were 
treated with BFA and then either visual-
ized directly or fixed and stained for 
endogenous GM130. Arrows show 
colocalizing puncta, and the area 
inside the white box is enlarged in 
the inset. In untreated cells, endoge-
nous GM130 localizes only to the 
Golgi apparatus (Fig. S2). Online 
supplemental material is available at 
http://www.jcb.org/cgi/content/full/
jcb/200107045/DC1. Bars: (A) 130 
nm; (B) 5 m.
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GFP was cytoplasmic, and GRASP65–GFP and p58–GFP
were found in punctate structures. Using time-lapse imaging
we then followed the pathway whereby GRASP65 chimeras
relocated to peripheral structures. We found that they ap-
peared in these sites abruptly, without tracking out from the
Golgi region (Fig. 3 B and Video 1 available at http://
www.jcb.org/cgi/content/full/jcb.200107045/DC1). More-
over, this occurred before Golgi blinkout when Golgi enzymes
redistribute into the ER. This raised the possibility that rather
than representing Golgi remnants that are left behind after the
ER redistribution of Golgi enzymes, the punctate structures
containing GRASP65–GFP represent a new location where
these proteins are targeted and retained after BFA treatment.
 
BFA remnants colocalize with ER exit sites, whose 
distribution and morphology are unaffected by BFA
 
One potential location that p58 and Golgi matrix proteins
could relocate to in BFA-treated cells is ER exit sites, since BFA
is not thought to directly perturb COPII-dependent ER export
machinery (Orci et al., 1993; Lippincott-Schwartz et al., 2000).
A marker for these sites is Sec13–YFP (Hammond and Glick,
2000), which is a component of the COPII coat that mediates
vesicle budding from zones of transitional smooth ER (i.e., ER
exit sites) (Barlowe et al., 1994; Kuge et al., 1994). BFA did not
disturb the overall distribution of Sec13–YFP (Fig. 3 A), which
localized to punctate structures widely distributed in the cyto-
plasm that underwent little long-range motion (Hammond
and Glick, 2000). At the EM level, these structures showed no
apparent changes in morphology as a result of BFA treatment.
In both BFA-treated and untreated cells, immunogold-labeled
Sec13 was localized to the transitional ER that was adjacent to
vesicular tubular clusters (VTCs) (Fig. 4 A).
To investigate the possibility that the membranes at ER
exit sites serve to recruit Golgi proteins not retained in the
ER in BFA-treated cells, we compared the distribution of
 
Sec13–YFP to either p58–cyan fluorescent protein (CFP) or
the Golgi matrix proteins, GM130 and GRASP65. Strik-
ingly, in BFA-treated cells coexpressing p58–CFP and
Sec13–YFP, all of the p58-labeled puncta were found to co-
incide with Sec13 labeling (Fig. 4 B). Similarly, antibody la-
beling for GM130 in treated cells expressing Sec13–YFP or
GRASP65–GFP showed codistribution of these proteins
(Fig. 4 B). The distribution of GRASP65–GFP and GM130
antibody labeling within puncta completely overlapped,
whereas the distribution of Sec13 within puncta was slightly
offset from the Golgi proteins (Fig. 4 B, see inset).
COPII-coated transitional ER is normally in close vicinity
to VTCs at the ultrastructural level (Fig. 4 A; Bannykh et
al., 1996), so the likely explanation for the labeling pattern
seen in Fig. 4 B is that the Golgi proteins in BFA-treated
cells are more enriched in VTCs relative to transitional ER,
where Sec13 is most abundant. Immunogold EM labeling of
p58 in BFA-treated cells supported this interpretation. p58
labeling was found both in the ER and in a more concen-
trated form, as deduced from increased gold clustering, on
VTCs in close proximity to ER membranes (Fig. 4 A).
These results indicate that in BFA-treated cells, p58 and
Golgi matrix proteins relocate to membranes associated with
ER exit sites, while the ultrastructure of the ER exit sites
does not appear changed.
 
p58 and Golgi matrix proteins redistribute to ER exit 
sites in Arf1[T31N]-expressing cells
 
We next examined how the steady-state association of Golgi
proteins was affected by expression of the dominant inactive
mutant of Arf1, Arf1[T31N]. In Arf1[T31N]-expressing
cells, Arf1 is unable to exchange GDP for GTP, an effect
similar to that of BFA on Arf1 (Klausner et al., 1992;
Dascher and Balch, 1994). Since activated Arf1 on Golgi
membranes is required for the recruitment of the COPI coat
Figure 5. Constitutively inactive Arf1 or constitutively active Sar1 mutants that disrupt ER–Golgi trafficking also cause the relocation of 
Golgi components to ER exit sites. NRK cells stably expressing Sec13–YFP were either transfected with Arf1[T31N] or Sar1[H79G] alone and 
then fixed and stained for GM130, or were cotransfected with the GTPase mutant together with p58–CFP or GalT–CFP and then visualized 
directly. Arrows indicate colocalizing puncta. Bars, 5 m.
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(Donaldson et al., 1992), which is necessary for Golgi func-
tion, Golgi organization is profoundly affected in cells
expressing this mutant (Dascher and Balch, 1994). We
found that Golgi structures disappeared in cells expressing
Arf1[T31N], with Golgi components redistributing in a pat-
tern that was similar to the observed effect in BFA-treated
cells: Golgi enzymes were localized to the ER, COPI was re-
leased into the cytosol (unpublished data), and p58 and ma-
trix proteins were found in punctate peripheral structures
(Fig. 5). Importantly, the peripheral structures containing
p58 and Golgi matrix proteins were found to colocalize with
Sec13-labeled ER exit sites (Fig. 5, arrows), whose distribu-
tion was unaffected by Arf1[T31N] expression.
 
Golgi protein localization in cells expressing 
Sar1[H79G], a GTP-locked mutant
 
In Sar1[H79G]-expressing cells, Sar1 is stabilized in its con-
stitutively active GTP-bound form (Fig. 6 D; Aridor et al.,
1995). Previous work has shown that this results in the fail-
ure of cargo to be efficiently exported from the ER (Aridor
et al., 1995; Pepperkok et al., 1998). It has also been shown
to result in the redistribution of Golgi glycosylation enzymes
to the ER, whereas Golgi matrix proteins associate with
membranes in close proximity to the MTOC (Storrie et al.,
1998; Girod et al., 1999; Seemann et al., 2000). In cells ex-
pressing Sar1[H79G], we found the expected changes in the
distribution of Golgi enzymes and Golgi matrix proteins:
GalT–CFP was localized to the ER, and GM130 (and
GRASP65; unpublished data) was in juxtanuclear structures
next to the MTOC (Fig. 5). COPI was released into the cy-
tosol (unpublished data), presumably because activated Sar1
prevents the sequential association of COPI (Aridor et al.,
1995; Scales et al., 1997; Stephens et al., 2000). Further-
more, we found that p58–CFP, which undergoes rapid cy-
cling between the ER and the Golgi apparatus, was relocated
to juxtanuclear membranes similar to GM130, in addition
to localizing to the ER (Fig. 5).
When we looked at the distribution of Sec13–YFP in
Sar1[H79G]-expressing cells, we found that it codistributed
with GM130 and p58–CFP in juxtanuclear structures at the
expense of its usual punctate distribution (Fig. 5). Localiza-
tion of the Sar1 mutant protein directly by immunofluores-
cence revealed that only cells exhibiting a positive stain
showed the clustered phenotype for Sec13–YFP and Sar1 la-
bel (Fig. 6 A). Immunogold EM labeling of Sar1 in
Sar1[H79G]-expressing cells (Fig. 6 A) revealed that clusters
of vesicular tubular membranes, often in direct continuity
with the ER, were decorated with the immunogold label.
To exclude the possibility that Sar1[H79G] might be
causing aberrant recruitment of COPII to Golgi membranes
Figure 6. The COPII coat actively 
cycles on and off the membrane in cells 
with disrupted ER–Golgi trafficking. (A) 
NRK cells stably expressing Sec13–YFP 
were transfected with Sar1[H79G]. They 
were fixed and then stained for either 
immunofluorescence or immunoEM 
with the HA epitope on the Sar1 con-
struct. (B) Photobleaching of Sec13–YFP 
labeled structures in living cells. Cells 
were either left untreated, BFA-treated, 
or expressing Sar1[H79G] as indicated. 
The marked area was photobleached 
and fluorescence recovery was subse-
quently monitored. The arrows point to 
Sec13-labeled puncta before bleaching 
and following recovery. (C) Mean 
fluorescence intensity of the bleached 
region and nonbleached pools of 
Sec13–YFP were determined at the 
times indicated, and expressed as a
percentage of the prebleach ratio 
between these values. (D) A model 
depicting the GTPase cycle of Sar1, 
indicating where the cycle is blocked in 
the mutants used in this study. Bars: (A, 
left) 5 m; (A, right) 130 nm; (B) 5 m.
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at the MTOC, we treated cells with BFA and found no
change in the juxtanuclear pattern of membranes in
Sar1[H79G]-expressing cells (unpublished data). Moreover,
in cells pretreated with BFA, microinjection of Sar1[H79G]
still caused MTOC redistribution of Sec13- and GM130-
labeled membranes whether or not BFA was washed out.
This indicated that the clustered structures are not of Golgi
origin. These findings suggest that rather than representing
residual Golgi elements depleted of glycosylation enzymes,
as previously reported by Seemann et al. (2000), the juxta-
nuclear membranes containing GM130 and p58–CFP in
Sar1[H79G]-expressing cells are clustered ER exit sites.
 
The COPII coat cycles on and off the membrane and 
actively recruits cargo in BFA-treated or
Sar1[H79G]-expressing cells
 
To determine whether COPII turnover at ER exit sites is
affected by BFA treatment or Sar1[H79G] expression,
FRAP experiments were performed in cells stably expressing
Sec13–YFP. In untreated cells, Sec13–YFP fluorescence re-
covered rapidly on photobleached peripheral puncta (Fig. 6,
B and C). Hence, Sec13–YFP is able to cycle on and off the
membrane in a manner similar to that seen previously with
Sec23–GFP chimeras (Stephens et al., 2000), indicating that
ER exit sites are actively exchanging COPII components
with the cytosolic pool in a localized fashion. Upon treat-
ment of cells with BFA, we found little change in the dy-
namic association of Sec13–YFP with ER exit sites (Fig. 6, B
and C). Similarly, when we looked at the effect of pho-
tobleaching Sec13–YFP in the Sar1[H79G]-induced clus-
ters, we found that Sec13 was still able to exchange on and
off the membrane, although the recovery was often incom-
plete (Fig. 6, B and C). Thus, the COPII coat on the ER
exit sites is still dynamically exchanging on and off mem-
 
branes in cells treated with BFA, but to a lesser extent in cells
expressing Sar1[H79G].
The dynamic association of the COPII coat at ER exit sites
has been interpreted as evidence for the constitutive function
of COPII vesicles in ER export (Antonny et al., 2001). We
therefore asked whether cargo proteins could be actively
recruited into COPII-coated structures in BFA-treated
or Sar1[H79G]-expressing cells. FRAP was used to assess
whether p58–GFP, which colocalized with COPII-contain-
ing structures in BFA-treated or Sar1[H79G]-expressing cells
(Figs. 4 B and 5), was stably associated with these membranes
or was still undergoing flux. Fluorescence was found to rap-
idly recover in p58–GFP-containing ER exit sites after pho-
tobleaching in BFA-treated or Sar1[H79G]-expressing cells,
similar to the rate of p58–GFP recovery after photobleaching
these sites in untreated cells (Fig. 7). In these experiments, we
depolymerized microtubules with nocodazole before pho-
tobleaching to prevent translocation of the peripheral struc-
tures containing p58–GFP. This allowed us to rule out the
possibility that recovery occurred by the movement of un-
bleached peripheral structures into the FRAP box. Thereby,
we were able to demonstrate that recovery occurred by the ex-
change of bleached p58–GFP molecules with unbleached
p58 molecules within the surrounding ER. Thus, in BFA-
treated or Sar1[H79G]-expressing cells, p58–GFP is consti-
tutively cycling between the ER and ER exit sites.
Matrix proteins, such as GRASP65, are not thought to cycle
through the ER, so how they relocate to ER exit sites under
BFA treatment or in Sar1[H79G]-expressing cells is unclear.
One suggestion has been that these proteins do not relocate to
new membranes at all under these conditions, but remain sta-
bly associated with Golgi membranes, transforming into Golgi
remnants as other Golgi components leave or dissociate from
the Golgi apparatus (Seemann et al., 2000). However, our
Figure 7. Golgi components are actively recruited to ER exit sites in cells with disrupted ER–Golgi trafficking. Using NRK cells stably 
expressing p58–GFP or GRASP65–GFP, untreated cells were incubated on ice for 15 min to depolymerize microtubules. 1 g/ml nocodazole 
was added to prevent motion of preGolgi intermediates and cells were imaged immediately. BFA-treated cells were incubated with 5 g/ml 
BFA for 30 min and then prepared in the same way before imaging. Sar1[H79G]-expressing cells were transiently transfected with the mutant 
Sar1 construct 16 h before imaging. The marked area was photobleached and fluorescence recovery was subsequently monitored. The 
arrows point to puncta before bleaching and following recovery. Bars, 5 m.
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finding that GRASP65–GFP dynamically associates with, and
dissociates from, Golgi membranes through cytoplasmic ex-
change (Figs. 1 B and 2) raised the possibility that GRASP65–
GFP might relocate to ER exit sites by dissociating from Golgi
membranes and then reassociating with membranes that have
redistributed to ER exit sites. We tested this hypothesis by
performing FRAP experiments in GRASP65–GFP-express-
ing cells that were treated with BFA or were expressing
Sar1[H79G]. Strikingly, fluorescence was found to fully re-
cover in GRASP65–GFP-containing ER exit sites within 20 s
in BFA-treated or Sar1[H79G]-expressing cells, similar to the
rate of recovery in untreated cells (Fig. 7). This data argues
against the idea that the GRASP65–GFP-containing mem-
branes in BFA-treated or Sar1[H79G]-expressing cells repre-
sent Golgi remnants with stable association of GRASP65.
Rather, they suggest that in these cells GRASP65–GFP has re-
distributed by a process involving dissociation from Golgi
membranes and reassociation with membranes at ER exit sites.
 
All Golgi components relocate to the ER in cells 
expressing the GDP-locked mutant Sar1[T39N]
 
The above findings suggest that BFA remnants and Sar1-
induced clusters reflect the dynamic recruitment of p58 and
Golgi matrix proteins to membranes at ER exit sites, either
by retrieval to the ER and subsequent export, or by direct
membrane binding from the cytoplasm. To test whether such
recruitment depends on the activity of the COPII coat
machinery, we used the Sar1 dominant negative mutant,
Sar1[T39N], which is unable to exchange GDP for GTP and
is blocked in an inactive state (Fig. 6 D; Kuge et al., 1994).
In cells expressing the Sar1[T39N] mutant protein, ER
exit sites were no longer detectable by Sec13–YFP labeling,
suggesting that COPII function was completely disrupted in
these cells. Sec13–YFP was now diffusely localized through-
out the ER, as was Sar1 (Fig. 8 A). The ER itself, visualized
at the EM level using Sar1 immunogold labeling, was more
abundant and enlarged, likely due to the buildup of secre-
tory cargo that was unable to enter the secretory pathway in
these cells (Bonfanti et al., 1998).
When we examined the distribution of Golgi markers
in cells expressing Sar1[T39N] (Fig. 8 B), we found that
there were no longer any puncta or clusters enriched in p58–
GFP, GRASP65–GFP, or the endogenous matrix protein
GM130. Instead, these markers were now relocated to ER
membranes that also contained Golgi glycosylation en-
zymes. In the complete absence of ER export activity, there-
Figure 8. The constitutively inactive Sar1[T39N] 
mutant causes disruption of ER exit sites and 
redistribution of all Golgi components to the ER. 
(A) NRK cells stably expressing Sec13–YFP were 
transfected with Sar1[T39N]. They were fixed and 
then stained for either immunofluorescence or 
immunoEM with the HA epitope on the Sar1 con-
struct. (B) NRK cells stably expressing GalT–CFP 
were cotransfected with Sar1[T39N] and either 
p58–YFP or GRASP65–GFP. 16 h after transfec-
tion, cells were either visualized directly or fixed 
and stained for endogenous GM130. Note that in 
control cells, i.e., those not expressing Sar1[T39N], 
staining for endogenous GM130 and transiently 
transfected GRASP65–GFP is restricted to the 
Golgi and has no ER background (Fig. S2). Online 
supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb/200107045/DC1. 
Bars: (A, left) 5 m; (A, right) 650 nm; (B) 5 m.
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Discussion
 
Recently, it has been suggested that although many Golgi
proteins circulate through the ER, matrix proteins do not.
Instead, these proteins have been proposed to comprise a
higher order architecture of the Golgi apparatus that can ex-
ist independently of enzyme-containing membranes and
thereby serve as a template for Golgi growth and renewal
(Pelletier et al., 2000; Seemann et al., 2000). In this paper
we have tested this hypothesis using live cell imaging tech-
niques and EM, and we demonstrate that this is not the case.
We show that the Golgi matrix proteins undergo constant
exchange on and off Golgi membranes. Moreover, when ER
export is inhibited and Golgi enzymes redistribute into the
ER, we find that there are no residual Golgi membranes left
behind. Rather, all Golgi components redistribute to the
ER, the cytoplasm, or dynamically associate with ER exit
sites (Fig. 9). These results suggest that events operating at
ER exit sites are crucial for setting in motion the steps
involved in building and maintaining the Golgi appara-
tus, whose membranes are in a dynamic steady-state with
the ER.
 
Testing the template model of the Golgi apparatus
 
A key prediction of the template model is that there are sta-
bly associated proteins on Golgi membranes that serve as a
scaffold or template for Golgi growth and remodeling. To
test this hypothesis, we used a photobleaching assay to deter-
mine whether any Golgi proteins were permanently associ-
ated with Golgi membranes. GFP-tagged members of four
different Golgi protein classes (i.e., enzyme, itinerant, ma-
trix, and coat) were tested. Our results revealed that none
were stably associated with Golgi membranes, since after se-
lective photobleaching, in all cases, fluorescence recovered
into the Golgi area.
For GalT–GFP and p58–GFP, representing the glycosyla-
tion enzyme and itinerant classes of Golgi proteins, respec-
tively, recovery occurred on a time scale of minutes and was
dependent on microtubule-driven membrane delivery from
the ER. The half-time for recovery of GalT–GFP was slow,
relative to p58–GFP, which can be explained by the differ-
ences in the cycling rates of these two proteins through the
ER (Itin et al., 1995; Klumperman et al., 1998; Zaal et al.,
1999). Surprisingly, GRASP65–GFP, which is a member of
the matrix family of Golgi proteins, was not stably associated
with Golgi membranes, as would be predicted by the tem-
plate model of the Golgi apparatus. Recovery of GRASP65–
GFP occurred within 20 s of Golgi photobleaching and did
not depend on the presence of microtubules, which are re-
quired for the transport of membrane-bound ER to Golgi
intermediates. Its recovery rate was similar to that found for
the coat protein 
 

 
COP–GFP, which is known to continu-
ously bind to and release from Golgi membranes. Thus,
rather than stably binding Golgi membranes, GRASP65–
GFP is dynamically associating in a manner reminiscent of a
Golgi coat protein.
Although it is possible that the addition of the GFP tag to
GRASP65–GFP changes it from being stably to dynamically
associated with Golgi membranes, we believe this is unlikely.
In biochemical and morphological assays GRASP65–GFP
retains all of the properties of native GRASP65. These in-
Figure 9. Perturbants of ER to Golgi transport: summary of their 
effects on protein distributions within, and the morphology of, the 
ER–Golgi system. (A) Normal steady-state distributions of COPII, 
COPI, GalT, p58, and GRASP65 within ER–Golgi membranes. 
COPII, COPI, and GRASP65 rapidly exchange on and off mem-
branes with steady-state abundances of COPII on ER exit domains 
(shown as elaborate budding ER profiles) and COPI and GRASP65 
on Golgi structures. The formation of transport intermediates that 
are capable of translocating away from the ER and targeting to the 
Golgi is envisioned to occur in two distinct stages. Stage I leads to 
the recruitment of selected classes of proteins (e.g., p58 and matrix 
proteins) through the dynamic exchange activity of COPII. This 
stage can be blocked by Sar1[T39N]. Stage II leads to the recruit-
ment of other classes of proteins (e.g., glycoslylation enzymes and 
plasma membrane–directed cargo), and is dependent on the 
exchange activity of the Arf1–coatomer system. This second stage is 
blocked by BFA, Arf1[T31N], and Sar1[H79G]. (B) The effect of 
blocking stage II by BFA, Arf1[T31N], or Sar1[H79G]. The 
Sar1–COPII system is still active under these conditions whereas the 
Arf1–coatomer system is disrupted, with COPI release into the 
cytoplasm. GRASP65 and p58 dynamically associate with ER export 
domains still functioning through Sar1/COPII activity. Glycosylation 
enzymes that have cycled out of preexisting Golgi structures, as 
well as newly synthesized proteins destined for the plasma 
membrane, are unable to be recruited to these sites in the absence 
of the Arf1–coatomer system. Golgi structure disassembles over 
time as its components redistribute back to the ER and secretory 
transport is halted. (C) The effect of blocking stage I with 
Sar1[T39N]. Both the Sar1–COPII and Arf1–coatomer systems are 
inhibited under these conditions. In the absence of all ER export 
activity, no sequestration and sorting within the ER of molecules 
that normally enter the secretory pathway occurs. COPII, assessed 
through Sec13–GFP, is diffusely localized along ER membranes, as 
is GRASP65 (and other matrix proteins), p58, and GalT. The Golgi 
structure disassembles as Golgi components cycling through the ER 
are unable to maintain its membranes.
 
fore, all Golgi identity is lost. The data thus support the
view of the Golgi as a steady-state system, whose mainte-
nance is dependent on ER export activities (Storrie et al.,
1998; Zaal et al., 1999).
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clude its ability to be myristoylated, its interactions with
GM130, its localization to Golgi membranes, and its redis-
tribution to peripheral or juxtanuclear sites in BFA-treated
cells or cells expressing the activated, GTP-bound mutant of
Sar1 (Sar1[H79G]), respectively (Barr et al., 1998; and this
study). In addition, Western blotting of whole cell extracts
for endogenous GRASP65 revealed it as residing in both cy-
tosolic and membrane fractions (Fig. S1 available online at
http://www.jcb.org/cgi/content/full/jcb.200107045/DC1),
consistent with the observed cytosolic and membrane pools
of GRASP65–GFP in living cells. These observations indi-
cate that members of all Golgi protein classes localize to
Golgi membranes dynamically, through either association/
dissociation with the cytoplasm or membrane cycling path-
ways through the ER. The lifetime for Golgi membrane as-
sociation is Golgi enzyme
 
 
 
 recycling protein 
 

 
 coat and
matrix proteins.
 
ER exit sites are functional and capable of recruiting 
specific classes of proteins when the Arf1–COPI system 
is disrupted by BFA or Arf1[T31N]
 
To understand what underlies the ability of the Golgi appa-
ratus to maintain and organize itself in the absence of long-
lived components, we examined how Golgi structure be-
comes disorganized under different treatments. We focused
first on the changes in Golgi structure that occur during
BFA treatment or with the overexpression of constitutively
inactive Arf1 (Arf1[T31N]). Both treatments caused the
same phenotype, including membrane dissociation of
COPI, redistribution of glycosylation enzymes into the ER,
loss of Golgi structure, and the formation of peripheral
structures with which recycling and matrix proteins were as-
sociated (Fig. 9). These structures have been proposed to
represent membranes left behind (i.e., Golgi remnants) after
Golgi enzymes have redistributed into the ER, they would
then serve as a template for rebuilding the Golgi apparatus
(Seemann et al., 2000). However, when we performed time-
lapse imaging of a BFA-treated cell expressing GRASP65–
GFP, we found that rather than being retained on Golgi
membranes during BFA treatment, GRASP65–GFP redis-
tributed to peripheral structures while Golgi stacks were still
apparent, and there was no evidence of these structures
tracking out from the Golgi apparatus. This suggested that
rather than being Golgi remnants, the peripheral structures
represented new membranes onto which GRASP65–GFP
dynamically redistributed in response to Arf1 inactivation.
The peripheral structures containing GRASP65–GFP and
p58–YFP in BFA-treated or Arf1[T31N]-expressing cells
were found to be localized at ER exit domains, whose ultra-
structure, comprised of budding ER profiles and tubulove-
sicular clusters, was normal. Immunogold EM combined
with fluorescence microscopy of the ER exit domains
showed that the COPII coat component, Sec13–YFP, was
present in the budding ER profiles, whereas p58–YFP,
GRASP65–GFP, and GM130 were enriched in the adjacent
tubulovesicular clusters. FRAP experiments showed that
Sec13–YFP exchanged on and off the ER exit sites at the
same rate as in control cells, suggesting that COPII activity
was not affected by COPI inactivation. The ER exit do-
mains actively recruited p58–YFP and GRASP65–GFP
 
from surrounding areas of the cell, since both molecules rap-
idly recovered into single, photobleached peripheral struc-
tures. For p58–GFP, which was localized in the ER in addi-
tion to the ER exit domains, such movement presumably
occurred by membrane cycling. For GRASP65–GFP, which
is not localized to ER membranes but found dispersed in the
cytoplasm at low levels when not localized on membranes,
such exchange would occur by direct membrane association/
dissociation.
The above results indicate that in the absence of the Arf1–
coatomer system, ER exit domains still persist and are capa-
ble of recruiting some (e.g., p58, GRASP65, and GM130)
but not other (e.g., Golgi enzymes and secretory cargo like
vesicular stomatitis virus G protein [unpublished data])
membrane components. This implies that the activity of the
Arf1–COPI system is necessary for the differentiation of ER
export domains, subsequent to the activity of Sar1–COPII,
into more complex structures by enabling the recruitment of
the diverse array of membrane proteins that populate the
secretory pathway. This could potentially occur through
lipid partitioning, or by protein stabilization or concentra-
tion mechanisms (Lavoie et al., 1999; Martínez-Menárguez
et al., 1999), since COPI has been shown to interact with
the KKXX motif of recycling proteins (Cosson and Letour-
neur, 1994; Tisdale et al., 1997). Because the rate of p58–
GFP cycling in and out of ER export domains, assessed by
photobleaching, was the same in cells treated with or with-
out BFA, trafficking of p58–GFP into and out of these sites
occurs independently of the Arf1–COPI system.
 
Cells expressing the GTP-locked Sar1[H79G] mutant 
still dynamically recruit specific classes of proteins to 
functional ER exit sites, which cluster in a
juxtanuclear location
 
Previously, Seemann et al. (2000) reported a juxtanuclear
phenotype for Golgi matrix proteins in cells expressing
Sar1[H79G] (also called Sar1pDN) that is locked in its GTP
bound form. They interpreted this phenotype as evidence that
matrix proteins comprise a stable scaffold of the Golgi appara-
tus that does not redistribute in response to a block in ER
to Golgi trafficking. When we examined cells expressing
Sar1[H79G], we found that the juxtanuclear membranes con-
taining matrix proteins and p58–YFP were closely associated
with ER exit sites defined by Sec13–YFP. This juxtanuclear
cluster was BFA insensitive and occurred with or without pre-
treatment with BFA, indicating that these membranes were
not of Golgi origin. FRAP experiments performed in cells co-
expressing Sec13–YFP and Sar1[H79G] revealed that Sec13–
YFP exchanged on and off the juxtanuclear membranes, sug-
gesting that they were active for ER export. In the same
respect, selective photobleaching of the juxtanuclear structures
revealed that p58–GFP underwent constitutive cycling be-
tween these membranes and the surrounding ER, whereas
GRASP65 rapidly associated/dissociated from the mem-
branes, presumably exchanging with a cytoplasmic pool.
These results indicate that in Sar1[H79G]-expressing
cells, no stable Golgi remnants persist when secretory trans-
port becomes inhibited. Instead, the juxtanuclear structures
containing the Golgi matrix and itinerant proteins present
in these cells represent ER export domains, active for the re-
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cruitment of some (including Golgi matrix and itinerant
proteins) proteins that populate the secretory pathway. The
phenotype of Sar1[H79G]-expressing cells thus resembles
that of BFA-treated or Arf1[T31N]-expressing cells. Under
all three conditions, COPI dissociates from membranes,
COPII components continue to exchange on/off ER export
sites, and Golgi structure is lost as Golgi enzymes redistrib-
ute to the ER and matrix/itinerant proteins relocate to ER
export domains. Why ER exit sites in Sar1[H79G]-express-
ing cells cluster around the MTOC, rather than remain as
widely distributed, punctate structures, is not clear. How-
ever, a similar phenotype has been described for the
redistribution of ER exit sites in cells treated with nocoda-
zole, which interferes with the microtubule-dependent deliv-
ery of membranes from these sites to the Golgi apparatus
and may reflect a response to localized retrograde trafficking
(Hammond and Glick, 2000). Alternatively, Sar1 may inter-
act directly with microtubule motors (Aridor et al., 2001),
and expression of the hydrolysis-resistant mutant protein in
vivo may thereby cause ER exit sites to cluster at the
MTOC.
 
Complete loss of ER exit sites in cells expressing the 
GDP-locked Sar1[T39N] mutant leads to the 
redistribution of all Golgi components to the ER
 
To test if the complete disruption of ER exit machinery
would result in the absorption of all Golgi components into
the ER, we expressed the constitutively inactive Sar1[T39N]
mutant that is blocked in the GDP-bound state. This mu-
tant was not examined in the Seeman et al. study (2001),
which proposes that matrix proteins generate a higher order
Golgi apparatus architecture that is never lost from cells. We
found that in Sar1[T39N]-expressing cells no ER exit sites
were visible by EM, and ER export machinery, including
Sar1 and Sec13–YFP, were diffusely localized to the ER,
which appeared swollen due to accumulated secretory cargo.
Importantly, Golgi matrix proteins, including GRASP65
and GM130, and the recycling protein p58–GFP were now
also redistributed into the ER, where Golgi enzymes were lo-
calized. Presumably, Sar1[T39N] causes the binding part-
ners for GRASP65 to also redistribute to the ER, thus the
exchange reaction is now ER–cytosol rather than Golgi–
cytosol. These results show that when ER export is inhibited
at its earliest stage (i.e., recruitment of COPII machinery),
all Golgi components equilibrate to the ER or cytosol (Fig.
9). Because there are no non-ER structures with which
Golgi components associate under these conditions, the data
demonstrate that there is no stable scaffold or higher order
architecture of the Golgi apparatus. Rather, maintenance
and biogenesis of the Golgi apparatus appear to be directly
dependent on the export activities of the ER.
 
Regenerating Golgi structure de novo
 
Warren and colleagues have used cytoplasts containing pe-
ripheral cytoplasm, but no nucleus or Golgi apparatus, to
test whether the Golgi apparatus can form de novo (Pelletier
et al., 2000). They found that the Golgi structure was regen-
erated after BFA washout in cytoplasts prepared from BFA-
treated cells. Cytoplasts prepared from untreated cells, how-
ever, did not reform a Golgi apparatus. The authors inter-
 
preted these data as evidence that the Golgi system is incapa-
ble of forming de novo and requires a preexisting scaffold or
Golgi remnant. They argued that Golgi structure reforms in
the BFA-treated cytoplast because it contains sufficient ER-
localized Golgi enzymes as well as so-called Golgi remnants
to allow Golgi reformation. Here, our data show that Golgi
remnants in BFA-treated cells are not of Golgi origin, but
represent ER export domains that selectively recruit matrix
and itinerant classes of Golgi proteins from the cytoplasm
and ER. A different explanation for the cytoplast results,
therefore, is that within the cytoplasts derived from un-
treated cells, there are only limited quantities of the various
components required to build the Golgi apparatus. This in-
cludes the Arf1–coatomer machinery, and potentially Golgi
matrix and other components, which, because they normally
distribute predominantly in the juxtanculear Golgi region,
are significantly depleted from the cytoplast. In BFA-treated
cells, sufficient levels of these components could distribute
either to the cytoplasm or associate dynamically with ER exit
sites in the cytoplast. Removal of BFA, which activates
Arf1–coatomer, would then result in Golgi structures nucle-
ating at ER exit domains, as Golgi enzymes and other cargo
now exit the ER. This is a de novo process since the ER ex-
port domains are not of Golgi origin but are derived from
the ER. The microsurgical results of Pelletier et al. (2000),
therefore, are fully consistent with the idea that cells can dy-
namically assemble a Golgi apparatus de novo without re-
quiring a preexisting Golgi template.
In summary, we have demonstrated that all classes of
Golgi components dynamically associate with the Golgi ap-
paratus, either by membrane cycling pathways or by direct
association/dissociation. When this dynamic behavior is dis-
rupted, Golgi structure breaks down and disappears within
cells. An important question that now needs to be addressed
is how the Golgi structure is nucleated and maintained in
the absence of stable components. Our data suggest that the
Sar1–COPII and Arf1–coatomer systems jointly serve this
role. The sequential activity of these two coat protein sys-
tems would underlie the maintenance of existing Golgi
structures and the biogenesis of new ones based on their
ability, as shown in this study, to recruit the broad spectrum
of Golgi proteins to ER export domains.
 
Materials and methods
 
DNA constructs and cell transfection
 
Plasmids expressing p58–CFP and p58–YFP were synthesized by first sub-
cloning ss-GFP from the vector described in Nehls et al. (2000) in place of
EGFP in pEGFP-C3 vector (CLONTECH Laboratories, Inc.). EGFP was re-
placed by ECFP or EYFP, and then p58 cDNA (from R.F. Pettersson, Lud-
wig Institute for Cancer Research, Stockholm, Sweden) lacking its own sig-
nal sequence was inserted into the multiple cloning site. GalT–YFP and
GalT–CFP were created as described previously (Zaal et al., 1999; Nichols
et al., 2001). GRASP65-GFP was from F.A. Barr (Max-Planck-Institute of
Biochemistry, Martinsried, Germany; Barr et al., 1998). 
 

 
COP–GFP was
created by inserting bovine 
 

 
COP cDNA (from F. Wieland, EMBL, Heidel-
berg, Germany) into the CLONTECH pEGFP-C3 vector (Presley et al.,
1998). The Sec13–YFP construct was from B.S. Glick (University of Chi-
cago, Chicago, IL) (Hammond and Glick, 2000). The Sar1[T39N] plas-
mid was created as described previously (Zaal et al., 1999) and the
Sar1[H79G] plasmid was constructed in the same manner (with cDNA
from O. Kuge, National Institute of Health, Tokyo, Japan). The Arf1[T31N]
construct was created as described previously (Peters et al., 1995).
All cells were grown in DME supplemented with 10% fetal calf serum,
glutamine, penicillin and streptomycin (Biofluids). Transient transfections
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were performed using FuGENE 6 transfection reagent (Roche Molecular
Biochemicals) according to the manufacturer’s instructions. Stable cell
lines were produced by selection for G418 resistance (at 500 
 

 
g/ml;
GIBCO BRL) expressed by the appropriate plasmid.
 
Cell reagents and immunofluorescence
 
BFA (Epicentre Technologies) was used at 5 
 

 
g/ml for 30 min before fixa-
tion or visualization unless otherwise described; nocodazole, used at 1 
 

 
g/
ml, was from Sigma-Aldrich. The following antibodies were used: mAb to
GM130 (Transduction Laboratories), polyclonal anti-GRASP65 (from M.A.
de Matteis, Consorzio Mario Negri Sud, Milan, Italy), mAb to syntaxin 13
(StressGen Biotechnologies), polyclonal anti-GFP (Molecular Probes, Inc.),
monoclonal anti-HA.11 (BAbCO). Fluorescently labeled secondary anti-
bodies were from Southern Biotechnology Associates, Inc. Cells were pre-
pared for immunofluorescence microscopy as described (Sciaky et al.,
1997).
 
Microscopy
 
All fluorescence images were obtained with a Zeiss LSM 510 confocal mi-
croscope using 413 nm laser excitation for CFP, 488 nm for GFP or fluo-
rescein, 514 nm for YFP, and 543 nm for rhodamine. Filter sets were as
supplied by the manufacturer. Live cells were held at 35
 

 
C on the micro-
scope stage. Images of cells not intended for quantitation of fluorescence
intensities were captured with a 100
 

 
 1.4 NA objective using a pinhole
diameter equivalent to 1–2 Airey units. For quantitative photobleaching of
the Golgi complex, a 25
 

 
 0.8 NA objective was used with the pinhole set
fully open to collect fluorescence from the entire depth of the cell. Selec-
tive photobleaching was performed using 50 consecutive scans of the ap-
propriate laser line at full power and recovery was then monitored by
time-lapse imaging at low-intensity illumination. Images were analyzed
using the Zeiss LSM software or NIH Image software.
To stain p58–GFP, Sec13–YFP, and HA-tagged Sar1 mutants for immu-
noEM, transfected cells were fixed and incubated with anti-GFP or anti-HA
antibodies as described (Polishchuk et al., 2000). Cells were then labeled
with Fab fragments of secondary antibodies conjugated with 1.4 nm Nano-
gold particles (Nanoprobes, Inc.) and developed with the GoldEnhance
kit (Nanoprobes, Inc.). After gold labeling, cells were postfixed in OsO
 
4
 
,
dehydrated in alcohols, and embedded in Epon. Ultrathin sections were
cut on a Leica Ultracut microtome and observed in a Philips CM10 trans-
mission electron microscope.
 
Online supplemental material
 
The Quicktime movie alluded to in Fig. 3 B shows the redistribution of
GRASP65–GFP to ER exit sites upon addition of BFA. Fig. S1 shows a
Western blot of endogenous GRASP65 following basic cell fractionation.
Fig. S2 shows the immunofluorescence pattern of endogenous GM130 in
untreated cells. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200107045/DC1.
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